Government unleashes tiny insects to combat full-blown public crisis: 'The solution is laws addressing this source'
The South African government has a new weapon in its fight against invasive water plants: a tiny aquatic weevil from Florida, Devdiscourse reported.
The salvinia weevil is named for its favorite food. It eats massive quantities of common salvinia, a plant that is creeping across South Africa.
This water weed is an invasive species — a species that has traveled beyond its native environment to a new location where it is multiplying at a destructive pace. Left alone, it will take over, crowding out and killing off a wide range of other species and destroying the natural balance that has existed in that area for millennia.
In the case of salvinia, it was first sighted at Hartbeespoort Dam in 2011. Since then, it has spread as far as the Limpopo River, to the edge of Botswana. It clogs the water, interfering with the livelihoods of everyone who relies on the river as well as the diversity of water plants and the quality of the water.
The weevils are expected to multiply just as fast to address the problem. Crucially, they only eat salvinia.
"This biological control programme will be closely monitored to assess the weevil's progress and effectiveness in reducing common salvinia. Importantly, these weevils exclusively target the salvinia minima plant and do not pose risks to other aquatic vegetation, crops, or ornamental plants," said professor Julie Coetzee, deputy director of the Rhodes University Centre for Biological Control and principal scientist at the National Research Foundation's South African Institute for Aquatic Biodiversity, per Devdiscourse.
Water and Sanitation Deputy Minister Sello Seitlholo emphasized that a major cause of salvinia's spread, and one that must be addressed, is the excess nutrients in incorrectly processed wastewater.
"What is also important is for us to have serious discussions with municipalities in the upper catchment areas. The inadequate treatment of wastewater leads to high nutrient levels in the water, which in turn fuels the spread of invasive aquatic plants, degrading the ecosystem, affecting recreational activities, and hampering the local economy," Seitlholo said, per Devdiscourse.
The solution is a law to address this source of pollution — which will lead to cleaner, healthier water for all.
Should we be actively working to kill invasive species?
Absolutely
It depends on the species
I don't know
No — leave nature alone
Click your choice to see results and speak your mind.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
ReElement Technologies achieves milestone in high-purity gallium and terbium production
ReElement Technologies, a subsidiary of American Resources, has announced the production of ultra-high-purity gallium and terbium from defence-related feedstocks supplied by major US defence contractors. In April 2024, ReElement extended its exclusive rights to utilise ligand-assisted displacement (LAD) chromatography technology, which was developed at Purdue University, to encompass all types of feedstocks including rare earth ores. The technology is used at ReElement's Commercial Qualification Plant in Noblesville, Indiana, to produce materials of exceptional purity, cost-efficiency and environmental sustainability. ReElement's continuous chromatography process offers numerous advantages including the use of aqueous chemistry, which eliminates the need for toxic solvents. This process also boasts lower capital expenditures, high versatility, and modular and scalable capacity, which aligns with the increasing availability of feedstocks. Additionally, localised processing strengthens supply chain security and efficiency by reducing the need to transport raw ore globally. ReElement Technologies CEO Mark Jensen said: 'Our platform continues to demonstrate unmatched versatility and performance in the global marketplace, enabling us to produce ultra-pure critical minerals required by the US defence sector and broader high-tech industries. 'We take a collaborative approach – inviting partners to send their materials to us for evaluation and refinement. Multiple defence clients have recently visited our facility, validated our process firsthand, and are now converting those evaluations into commercial opportunities. 'There is a significant amount of legacy material within the defence industry that has been historically landfilled. Now we can economically recover and refine these metals at a cost structure competitive with or even below Chinese suppliers. This is a transformative development for the sector.' The refining platform, initially developed for pharmaceutical purification, has been adapted to separate rare earths and critical minerals effectively. ReElement's patented platform is programmable and can handle multiple feedstocks and minerals, allowing for rapid deployment across various locations and resource types. This method contrasts with traditional solvent extraction methods as it uses fewer chemicals, requires less space and generates minimal waste. This not only makes the process faster to permit but also simpler to co-locate near feedstock or end-use customers. This is particularly crucial for the US, which aims to establish independence in critical mineral supply chains and reduce reliance on single-source processing. Additionally, American Resources has secured strategic funding from South African investment firm Novare Holdings through ReElement Technologies. This investment aims to catalyse the expansion of rare earth element refining operations in Marion, Indiana, US, with approximately $150m in combined equity and debt financing to enhance ReElement's refining capabilities at its 42-acre site. "ReElement Technologies achieves milestone in high-purity gallium and terbium production" was originally created and published by Mining Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
a day ago
- Yahoo
US aid cuts threaten South Africa's status as powerhouse of HIV and tuberculosis research
South Africa risks losing its status as a powerhouse of HIV and tuberculosis research as sweeping American funding cuts jeopardise dozens of experimental trials. At least 27 HIV trials and another 20 TB trials in the country have been put at risk by Donald Trump's deep cuts to foreign assistance and global health spending, new analysis shows. Loss of the trials would hit research projects looking for new vaccines into both infections, as well as new long-lasting protective medicines and studies into the best way to treat children. Having intense HIV and TB epidemics as well as world class universities and research institutes has made South Africa a leader in combating the two diseases. Yet while the research has often been led by South African scientists, it has overwhelmingly been conducted with international funding, particularly with 20 years of generous United States government aid spending. Prof Salim Abdool Karim, director of the Centre for the Aids Program of Research in South Africa, said: 'The US is such a big player in our country – South Africa is a powerhouse in medical research because of what the US spends.' The bulk of funding for research came from the US National Institutes of Health (NIH), with the country receiving an estimated £111m ($150m) each year. Prof Ntobeko Ntusi, the president and chief executive of the South African Medical Research Council (SAMRC), said earlier this year: 'In many ways the South African health research landscape has been a victim of its own success, because for decades we have been the largest recipients of both [official development assistance] funding from the US for research [and] also the largest recipients of NIH funding outside of the US.' Now, unless alternative sources of money can be found, South African academic and research institutes could lose about 30 per cent of their annual income and may be forced to lay off hundreds of staff, the analysis found. 'There's been a huge dependence on US funding. The loss of it for South Africa means the cancellation of a huge amount of research,' said Tom Ellman, director of the MSF's Southern Africa Medical Unit (SAMU). The joint analysis by Treatment Action Group (TAG) and Doctors Without Borders (MSF) of NIH-funded research found 39 TB and HIV clinical research sites are under threat, placing at least 27 HIV trials and 20 TB trials at risk. The effect of cuts could be wider still, with research also funded through other US channels, including the US President's Emergency Plan for Aids Relief (Pepfar), which has been slashed by Donald Trump's administration. Lindsay McKenna, TB project co-director of TAG said: 'Public funding from the US government to South Africa is the scaffold on which pharmaceutical companies, philanthropies, and other governments invest in transformative TB and HIV science.' 'These ongoing funding disruptions by the US government don't just affect US-funded research projects, they put in peril a much wider ecosystem of global research.' Dr Ellman said a combination of the infections found in South Africa, its research base and its strong grass roots activism had combined, with US funding, to make the country so prominent in research. He said: 'For years, South Africa has spearheaded the research and development of critical innovative medical tools for the prevention, diagnosis, treatment and care of HIV and TB which have saved lives not just within South Africa's borders, but also in communities worldwide.' The country has more HIV patients than any other, with an estimated 8 million currently infected and 105,000 deaths annually. The high prevalence of HIV goes hand-in-hand with a high prevalence of tuberculosis, because TB takes advantage of patients' weakened immune systems. Tuberculosis is the biggest cause of death among those with HIV in South Africa, which recorded 54,000 TB deaths in 2023. At the same time, the country has strong research institutions and universities, and a history of medical innovation, including conducting the first heart transplant in 1969. Finally, the history of the apartheid struggle, and later the fight in the early 2000s to get antiretroviral drugs in the face of government AIDS denialism, has produced well-organised and politically-engaged health activists. According to the joint analysis, HIV trials now at risk include studies into using broadly neutralising antibodies (bNAbs) to find a cure, and also trials into long-lasting anti-HIV preventative jabs. The Brilliant Consortium, a collaboration of African researchers led by the SAMRC working to develop an HIV vaccine, lost all funding even as it was about to begin an early stage vaccine trial. Dr Ellman said: 'I think it would be a disaster if we gave up on the hope of finding an effective vaccine for HIV. All of that has been done with South Africa and without access to South African research and communities, it's not going to be possible.' The emergence of some resistance to antiretroviral drugs has also highlighted the importance of trials to find new drugs which can deal with the phenomenon. HIV trials are also looking at honing and improving existing treatment regimes, as well as simplifying and rolling out expensive techniques first used in the developing world. TB trials at risk include studies for new drugs and shorter, safer regimens for treatment and prevention. The cuts have a ripple effect beyond individual trials, because they also weaken research infrastructure which is used and relied on by other funders. That could have a knock-on effect on trials looking at new TB jab possibilities, including the promising new M72/AS01E vaccine candidate. South Africa is now scrabbling for alternative sources of funding to try to salvage as many of the research projects as possible. Dr Ellman said: 'We call on all potential donors to step up, as without sustained investment, we will never end these deadly epidemics.' Protect yourself and your family by learning more about Global Health Security Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
6 days ago
- Yahoo
Dehorning of S.African rhinos slashed poaching: study
The dehorning of rhinos resulted in a nearly 80-percent reduction in the poaching of the animals during a seven-year study in a major South African conservation area, researchers said Thursday. Sawing off the sought-after horns was also a fraction of the cost of other counter-poaching measures such as deploying rangers or tracking dogs, according to the study published in the journal Science. The study was carried out between 2017 and 2023 in 11 reserves around South Africa's famed Kruger National Park that protect the world's largest rhino population. During this period, some 1,985 rhinos were poached in the reserves in the Greater Kruger area despite $74 million spent mostly on reactive law enforcement measures that netted around 700 poachers, it said. By contrast, dehorning 2,284 rhinos cut poaching by 78 percent at just 1.2 percent of that budget, said the study published by the American Association for the Advancement of Science. "Some poaching of dehorned rhinos continued because poachers targeted horn stumps and regrowth, signalling the need for regular dehorning alongside judicious use of law enforcement," the study said. South Africa is home to most of the world's rhinos, including the critically endangered black rhino, and is a hotspot for poaching driven by demand in Asia where the horns are used in traditional medicine. Rhino horn is highly sought after on the black market, where the price by weight rivals that of gold and cocaine. Alongside ivory, the horns are coveted as status symbols or used in traditional medicine for their supposed aphrodisiac properties. "Ongoing socioeconomic inequality incentivises a large pool of vulnerable and motivated people to join, or poach for, criminal syndicates even when the risks are high," the researchers said. Corruption also played a role with gangs receiving insider tips to evade detection and arrest, they said. - Impacts unclear - "Although detecting and arresting poachers is essential, strategies that focus on reducing opportunities for and rewards from poaching may be more effective," the study said. It added, however, that "the effects of dehorning on rhino biology are still unclear, with present research suggesting that dehorning may alter rhino space use but not survival and reproduction." The co-authors of the study are from South Africa's Nelson Mandela University and the University of Cape Town, and various conservation groups including the Wildlife Conservation Network and United Kingdom's Save the Rhino International. South Africa had more than 16,000 rhinos at the end of 2023, mostly white rhinos, according to government data. But at least 34 rhinos were killed each month, the environment minister said in May. In 2024 South African scientists injected radioactive material into live rhino horns to make them easier to detect at border posts in a pioneering project aimed at curbing poaching. The radioactive material would not impact the animal's health or the environment in any way but make it poisonous for human consumption, according to the University of the Witwatersrand's radiation and health physics unit which spearheaded the initiative. Black rhinos are listed by the International Union for Conservation of Nature (IUCN) as critically endangered. ho/br/rlp
